Title:Clinical Features, Socioeconomic Status, Management, and Outcomes of
Acute Heart Failure: PEACE MENA Registry Phase I Results
Volume: 21
Issue: 4
Author(s): Hanan AlBackr, Khalid F. Alhabib*, Kadhim Sulaiman, Amal Jamee, Mohamed Sobhy, Salim Benkhedda, Sobhi Dada, Ayman Hammoudeh, Habib Gamra, Ahmed Al-Motarreb, Fahad Alkindi, Mohammad I Amin, Magdi G. Yousif, Hasan A. Farhan, Nadia Fellat, Wael Almahmeed, Mohammad Al Jarallah, Prashanth Panduranga, Magdy Abdelhamid, Ihab Ghaly, Dahlia Djermane, Ahcene Chibane, Hadi Skouri, Mohamad Jarrah, Hassen Amor, Nora K. Alsagheer, Mohammed A. Hozayen, Hosameldin S. Ahmed, Muhammad Ali, Anhar Ullah, Ayman Al Saleh and Faiez Zannad
Affiliation:
- Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud Medical City, King Saud University, Riyadh, Saudi Arabia
Keywords:
Acute heart failure, Middle East, North Africa, PEACE MENA, AHF, HFrEF.
Abstract:
Introduction: PEACE MENA (Program for the Evaluation and Management of Cardiac
Events in the Middle East and North Africa) is a prospective registry in Arab countries for in-patients
with acute myocardial infarction (AMI) or acute heart failure (AHF). Here, we report the baseline characteristics
and outcomes of in-patients with AHF who were enrolled during the first 14 months of the
recruitment phase.
Methods: A prospective, multi-centre, multi-country study including patients hospitalized with AHF
was conducted. Clinical characteristics, echocardiogram, BNP (B-type natriuretic peptide), socioeconomic
status, management, 1-month, and 1-year outcomes are reported.
Results: Between April 2019 and June 2020, a total of 1258 adults with AHF from 16 Arab countries
were recruited. Their mean age was 63.3 (±15) years, 56.8% were men, 65% had monthly income
≤US$ 500, and 56% had limited education. Furthermore, 55% had diabetes mellitus, 67% had hypertension;
55% had HFrEF (heart failure with reduced ejection fraction), and 19% had HFpEF (heart failure
with preserved ejection fraction). At 1 year, 3.6% had a heart failure-related device (0-22%) and 7.3%
used an angiotensin receptor neprilysin inhibitor (0-43%). Mortality was 4.4% per 1 month and 11.77%
per 1-year post-discharge. Compared with higher-income patients, lower-income patients had a higher
1-year total heart failure hospitalization rate (45.6 vs 29.9%, p=0.001), and the 1-year mortality difference
was not statistically significant (13.2 vs 8.8%, p=0.059).
Conclusion: Most of the patients with AHF in Arab countries had a high burden of cardiac risk factors,
low income, and low education status with great heterogeneity in key performance indicators of AHF
management among Arab countries.
